Cargando…

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?

Detalles Bibliográficos
Autores principales:	Han, Eugene, Lee, Yong-ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577344/ https://www.ncbi.nlm.nih.gov/pubmed/37584065 http://dx.doi.org/10.3350/cmh.2023.0250

Ejemplares similares

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023)

Fatty liver in lean patients: is it a different disease?
por: Verdelho Machado, Mariana, et al.
Publicado: (2012)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
por: Yun, Yeojun, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center
por: Alsuhaibani, Khalid A., et al.
Publicado: (2021)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
por: Li, Hui, et al.
Publicado: (2019)

Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease
por: Iritani, Soichi, et al.
Publicado: (2020)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
por: Liu, Lu, et al.
Publicado: (2022)

Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China
por: Lan, Yanqi, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in lean individuals
por: Albhaisi, Somaya, et al.
Publicado: (2019)

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus
por: Zhang, Xingxing, et al.
Publicado: (2022)

Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
por: Boonchai, Punyisa, et al.
Publicado: (2022)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians
por: Lee, Sunyoung, et al.
Publicado: (2022)

Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study
por: Li, Jie, et al.
Publicado: (2023)

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease
por: Shen, Nan, et al.
Publicado: (2023)

Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
por: Young, Steven, et al.
Publicado: (2020)

Reduced Equol Production and Gut Microbiota Features in Men With Lean Nonalcoholic Fatty Liver Disease
por: Iino, Chikara, et al.
Publicado: (2022)

Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality
por: Golabi, Pegah, et al.
Publicado: (2019)

Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study
por: Wang, Wenting, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
por: Patel, Ankoor H., et al.
Publicado: (2023)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
por: Cho, Yoosun, et al.
Publicado: (2022)

Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia
por: Khayyat, Yasir Mohammed
Publicado: (2021)

Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population
por: Li, Min-ran, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
por: Kumar, Ramesh, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals
por: Aneni, Ehimen C., et al.
Publicado: (2022)

Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
por: Hirose, Shunji, et al.
Publicado: (2020)

Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup
por: Hsu, Chiao-Lin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fakgh642fv3d92v6k13hgq9sid